Swiss National Bank
DNTH icon

Swiss National Bank’s Dianthus Therapeutics DNTH Stock Holding History

Swiss National Bank’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.19M Buy
73,800
+4,800
+7% +$419K ﹤0.01% 1226
2026
Q1 		$5.79M Buy
69,000
+37,600
+120% +$2.18M ﹤0.01% 1279
2025
Q4 		$1.29M Buy
+31,400
New +$1.22M ﹤0.01% 2062
2025
Q1 		– Sell
-14,400
Closed -$314K – 2413
2024
Q4 		$314K Sell
14,400
-2,900
-17% -$74.6K ﹤0.01% 2429
2024
Q3 		$474K Hold
17,300
– – ﹤0.01% 2442
2024
Q2 		$448K Buy
+17,300
New +$416K ﹤0.01% 2430

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Swiss National Bank's DNTH Position: Q2 2026 in Review

Swiss National Bank increased its Dianthus Therapeutics (DNTH) stake by 7% in Q2 2026, buying an estimated $419K and bringing the position to 73,800 shares worth $7.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Swiss National Bank first reported a position in DNTH in Q2 2024 and has held it in 6 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Swiss National Bank held 73,800 shares of Dianthus Therapeutics worth $7.19M as of Q2 2026.
  • Swiss National Bank bought 4,800 Dianthus Therapeutics shares in Q2 2026, an estimated $419K.
  • Dianthus Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1226 holding.
  • Swiss National Bank first reported a position in Dianthus Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.